These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10627434)

  • 1. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.
    Elkayam O; Paran D; Milo R; Davidovitz Y; Almoznino-Sarafian D; Zeltser D; Yaron M; Caspi D
    Ann Rheum Dis; 2000 Jan; 59(1):77-80. PubMed ID: 10627434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
    Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
    Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolic complications of intravenous immunoglobulin treatment.
    Vucic S; Chong PS; Dawson KT; Cudkowicz M; Cros D
    Eur Neurol; 2004; 52(3):141-4. PubMed ID: 15479982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.
    Lidar M; Masarwa S; Rotman P; Carmi O; Rabinowicz N; Levy Y
    Immunol Res; 2018 Dec; 66(6):668-674. PubMed ID: 30565202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarction associated with intravenous immune globulin.
    Stenton SB; Dalen D; Wilbur K
    Ann Pharmacother; 2005 Dec; 39(12):2114-8. PubMed ID: 16288078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
    Tufan F; Kamali S; Erer B; Gul A; Inanc M; Ocal L; Konice M; Aral O
    Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: intravenous immunoglobulin therapy and thromboembolic complications.
    Katz U; Shoenfeld Y
    Lupus; 2005; 14(10):802-8. PubMed ID: 16302674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature.
    Zaidan R; Al Moallem M; Wani BA; Shameena AR; Al Tahan AR; Daif AK; Al Rajeh S
    Eur J Neurol; 2003 Jul; 10(4):367-72. PubMed ID: 12823487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration.
    Davé S; Hagan J
    Ann Allergy Asthma Immunol; 2007 Dec; 99(6):567-70. PubMed ID: 18219840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
    Ahsan N
    J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases.
    Katz U; Shoenfeld Y; Zandman-Goddard G
    Curr Pharm Des; 2011; 17(29):3166-75. PubMed ID: 21864262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic complications after intravenous immunoglobulin therapy in two patients.
    Emerson GG; Herndon CN; Sreih AG
    Pharmacotherapy; 2002 Dec; 22(12):1638-41. PubMed ID: 12495174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System.
    Benadiba J; Robitaille N; Lambert G; Itaj NK; Pastore Y
    Transfusion; 2015 Mar; 55(3):571-5. PubMed ID: 25355613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure.
    Bentley P; Rosso M; Sadnicka A; Israeli-Korn S; Laffan M; Sharma P
    J Clin Pharm Ther; 2012 Jun; 37(3):286-90. PubMed ID: 21767284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: a two-year study.
    Rajabally YA; Kearney DA
    J Neurol Sci; 2011 Sep; 308(1-2):124-7. PubMed ID: 21679973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy.
    Nakano Y; Hayashi T; Deguchi K; Sato K; Hishikawa N; Yamashita T; Ohta Y; Takao Y; Morio T; Abe K
    J Neurol Sci; 2016 Feb; 361():9-12. PubMed ID: 26810508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.